SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-24-013444
Filing Date
2024-04-26
Accepted
2024-04-26 17:15:43
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A mbrx20240417_10ka.htm   iXBRL 10-K/A 330291
2 EXHIBIT 31.3 ex_657863.htm EX-31.3 4756
3 EXHIBIT 31.4 ex_657864.htm EX-31.4 5027
  Complete submission text file 0001437749-24-013444.txt   589489

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20231231.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20231231_def.xml EX-101.DEF 17405
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20231231_lab.xml EX-101.LAB 23725
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20231231_pre.xml EX-101.PRE 18445
19 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240417_10ka_htm.xml XML 8310
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37758 | Film No.: 24885259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)